Aurinia Pharmaceuticals (AUPH) Change in Inventory (2020 - 2026)

Aurinia Pharmaceuticals has reported Change in Inventory for 7 years, with the latest figure at $720000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 89.67% year-over-year to $720000.0; the trailing twelve-month figure through Mar 2026 stood at $215000.0 (down 96.66% YoY), and the FY2025 full-year result was $6.5 million, up 1454.72% from the prior year.
• Change in Inventory for Q1 2026 stood at $720000.0, down from $897000.0 in the prior quarter.
• The five-year high for Change in Inventory was $7.0 million in Q1 2023, with the low at -$1.7 million in Q3 2025.
• Historically, Change in Inventory has averaged $1.9 million across 5 years, with a median of $614000.0 in 2022.
• The largest YoY upside for Change in Inventory was 12341.07% in 2025 against a maximum downside of 1130.22% in 2025.
• Aurinia Pharmaceuticals' Change in Inventory stood at $614000.0 in 2022, then soared by 1021.34% to $6.9 million in 2023, then sank by 92.53% to $514000.0 in 2024, then surged by 74.51% to $897000.0 in 2025, then dropped by 19.73% to $720000.0 in 2026.
• The last three Change in Inventory figures came in at $720000.0 (Q1 2026), $897000.0 (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.